Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now reflects an updated platform revision to v3.6.5, indicating an underlying system update; user-facing study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-08-08T08:53:57.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.3 to v3.6.4, indicating an updated version of the page. This update appears to be a backend/content-management change with no substantive modification to the trial details.
    Difference
    0.0%
    Check dated 2026-07-24T22:35:34.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    New update timestamps were added and older ones removed, reflecting the latest revision history of the study record.
    Difference
    0.1%
    Check dated 2026-07-10T16:51:55.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Three new study sites were added (CommonSpirit Saint Joseph Hospital Bardstown; CommonSpirit Saint Joseph Medical Center East Lexington; CommonSpirit Saint Joseph Hospital London), and three existing sites were removed (Flaget Memorial Hospital; Saint Joseph Hospital East; Saint Joseph London). The page includes a new revision tag (v3.6.3).
    Difference
    0.1%
    Check dated 2026-07-03T14:44:55.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 on the page, reflecting a software/layout update. This change does not modify the study content or the information presented about the trial.
    Difference
    0.0%
    Check dated 2026-06-26T11:51:01.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    Creighton University Medical Center in Omaha was removed from the study site list and the total number of locations decreased from 281 to 280. This change reflects updated site availability for the trial.
    Difference
    0.1%
    Check dated 2026-06-19T07:41:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.